Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fenner, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fenner, H; Rau, R
      Influence of gold versus methotrexate treatment on cytokine-profiles and markers of bone and cartilage destruction

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    2. Woodworth, TG; Furst, DE; Strand, V; Kempeni, J; Fenner, H; Lau, CS; Miller, F; Day, R; Lipani, J; Brooks, P
      Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: Towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies

      JOURNAL OF RHEUMATOLOGY
    3. Rau, R; Herborn, G; Fenner, H
      Links between joint damage and disability

      RHEUMATOLOGY
    4. Rau, R; Herborn, G; Zueger, S; Fenner, H
      The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years

      JOURNAL OF RHEUMATOLOGY
    5. Brooks, P; Emery, P; Evans, JF; Fenner, H; Hawkey, CJ; Patrono, C; Smolen, J; Breeveld, F; Day, R; Dougados, M; Ehrich, EW; Gijon-Banos, J; Kvien, TK; Van Rijswijk, MH; Warner, T; Zeidler, H
      Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

      RHEUMATOLOGY
    6. FENNER H
      IMMUNOPHARMACOLOGICAL PROFILE AND THERAPEUTIC PERSPECTIVES OF ANTI-TNF-ALPHA-THERAPIES

      Zeitschrift fur Rheumatologie
    7. RAU R; SANDER O; DENBROEDER A; VANRIEL PLCM; VANDERPUTTE L; KRUGER K; SCHATTENKIRCHER M; FENNER H; LASSMANN A; KUPPER H; KEMPENI J
      LONG-TERM EFFICACY AND TOLERABILITY OF MULTIPLE IV DOSES OF THE FULLYHUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    8. VANDEPUTTE LBA; VANRIEL PLCM; DENBROEDER A; SANDER O; RAU R; BINDER C; KRUGER K; SCHATTENKIRCHER M; FENNER H; SALFELD J; BANKMANN Y; KUPPER H; KEMPENI J
      A SINGLE-DOSE PLACEBO-CONTROLLED PHASE-1 STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    9. SCHATTENKIRCHNER M; KRUGER K; SANDER O; RAU R; KROOT EJ; VANRIEL PLCM; VANDEPUTTE L; FENNER H; KEMPENI J; KUPPER H
      EFFICACY AND TOLERABILITY OF WEEKLY SUBCUTANEOUS INJECTIONS OF THE FULLY HUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS- RESULTS OF A PHASE-I STUDY

      Arthritis and rheumatism
    10. FENNER H
      DIFFERENTIATING AMONG NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES

      Seminars in arthritis and rheumatism
    11. RAU R; HERBORN G; FENNER H
      SHORT-TERM RADIOGRAPHIC DISEASE PROGRESSION IS NOT PREDICTING LONG-TERM OUTCOME IN 1 4 OF RA PATIENTS FOLLOWED OVER 6 YEARS/

      Arthritis and rheumatism
    12. FENNER H; HERBORN G; RAU R
      JOINT SWELLING, ESR CRP AND PREDICTION OF LONG-TERM RADIOGRAPHIC DISEASE PROGRESSION IN RA/

      Arthritis and rheumatism
    13. FENNER H
      MELOXICAM - A VIEWPOINT

      Drugs
    14. FENNER H; ZUEGER S
      ASSESSMENT OF RADIOGRAPHIC DISEASE PROGRESSION IN COMPARATIVE DRUG TRIALS IN RA - THE ROLE OF PATIENT STRATIFICATION FOR HLA-DRB1 AND RF STATUS

      Arthritis and rheumatism
    15. HERBORN G; RAU R; SANDER O; ZUEGER S; FENNER H
      CRP, ESR, HLA-DRB1 HAPLOTYPE, RF STATUS AND LONG-TERM DISEASE PROGRESSION IN RA

      Arthritis and rheumatism
    16. FENNER H
      TNF INHIBITOR, A NOVEL THERAPEUTIC PERSPE CTIVE IN CHRONIC-INFLAMMATORY RHEUMATIC DISEASES

      Zeitschrift fur Rheumatologie
    17. NEVES A; VENCATO I; HORNER M; FENNER H
      -N,2-KAPPA-N',1-2-KAPPA-O-2-BIS(DIOXOVANADIUM)(1+) IODIDE DIHYDRATE, [(VO2)(2)(TPHPN)]I.2H2O

      Acta crystallographica. Section C, Crystal structure communications
    18. ANDUS T; DAIG R; LOCK G; HOLLERBACH S; CAESAR I; VOGL D; ASCHENBRENNER E; FENNER H; SCHOLMERICH J; GROSS V
      BALANCE BETWEEN PRO-CYTOKINES AND ANTIINFLAMMATORY-CYTOKINES IN THE COLONIC MUCOSA IN INFLAMMATORY BOWEL DISEASES (IBD)

      Gastroenterology
    19. RAU R; HERBORN G; SANDER O; ZUEGER S; FENNER H
      ABSENCE OF AN IMPACT OF HLA-DRB1 ALLELES ON DISEASE PROGRESSION OF RAPATIENTS 7 YEARS AFTER EARLY INTRODUCTION OF MTX OR IM GOLD

      Arthritis and rheumatism
    20. FENNER H; ZUEGER S; TAYLOR D; SANDER O; HERBORN G; RAU R
      SUPPRESSION OF TUMOR-NECROSIS-FACTOR (TNF) AND TNF-MEDIATED EFFECTOR MECHANISMS BY METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    21. FENNER H; TAYLOR D; SCHATTENKIRCHNER M; FOLKERS G; ZUEGER S
      IMMUNOGENETIC PROFILES CORRELATE WITH PRO-MMP EXPRESSION IN RHEUMATOID-ARTHRITIS

      Acta orthopaedica Scandinavica
    22. FENNER H; TAYLOR D; FOLLKERS G; ZUEGER S
      THE TNF-MMP-MATRIX NETWORK AND SERUM MARKERS FOR CARTILAGE SYNTHESIS AND DEGRADATION

      Acta orthopaedica Scandinavica
    23. FENNER H
      DCT-ART - THE CONCEPT - COMMENT

      Journal of rheumatology
    24. ANDUS T; RATH H; CAESAR I; ASCHENBRENNER E; FENNER H; FALK W; SCHOLMERICH J; GROSS V
      ANTIINFLAMMATORY-CYTOKINES IN INFLAMMATORY BOWEL-DISEASE (IBD)

      Gastroenterology
    25. HANNON RA; BLUMSOHN A; GALATTI H; FENNER H; RUSSELL RGG; EASTELL R
      CYTOKINE RECEPTORS, RECEPTOR ANTAGONISTS AND POSTMENOPAUSAL BONE LOSS

      Journal of bone and mineral research
    26. NEVES A; HORNER M; FENNER H; STRAHLE J
      STRUCTURE OF AKIS-(2-PYRIDYLMETHYL)ETHYLENEDIAMINE]-VANADIUM(V) CHLORIDE MONOHYDRATE, [VO2(TPEN)]CL.H2O

      Acta crystallographica. Section C, Crystal structure communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 06:18:47